Ngiow, Shin Foong <br/><br/>
Prospects for TIM3-Targeted Antitumor Immunotherapy.  [electronic resource] 

 -  Cancer research  Nov 2011 
 - 6567-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-11-1487  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antigen-Presenting Cells--immunology<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Clonal Anergy--immunology<br/>Combined Modality Therapy<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Forecasting<br/>Hepatitis A Virus Cellular Receptor 2<br/>Humans<br/>Immunologic Memory--immunology<br/>Immunotherapy--methods<br/>Lymphocyte Activation--immunology<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Membrane Proteins--antagonists & inhibitors<br/>Mice<br/>Molecular Targeted Therapy<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Neoplasms--immunology<br/>Neoplasms, Experimental--immunology<br/>Receptors, Virus--antagonists & inhibitors<br/>T-Lymphocyte Subsets--immunology<br/>Tumor Microenvironment--immunology